We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for vanzacaftor, tezacaftor, deutivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
vanzacaftor, tezacaftor, deutivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
tablet
Indication
Treatment of Cystic Fibrosis
Therapeutic area
Oncology